Imo A Ebong1, Karol E Watson, David C Goff, David A Bluemke, Preethi Srikanthan, Tamara Horwich, Alain G Bertoni. 1. From the 1Loma Linda University Medical Center Transplantation Institute, Loma Linda, CA; 2Division of Cardiology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; 3Colorado School of Public Health, Aurora, CO; 4National Institutes of Health/Clinical Center, Bethesda, MD; 5Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; and 6Departments of Medicine and Epidemiology, Wake Forest University School of Medicine, Winston Salem, NC.
Abstract
OBJECTIVE: Menopause age can affect the risk of developing cardiovascular disease (CVD). The purpose of this study was to investigate the associations of early menopause (menopause occurring before age 45 y) and menopause age with N-terminal pro brain natriuretic peptide (NT-proBNP), a potential risk marker of CVD and heart failure. METHODS: Our cross-sectional study included 2,275 postmenopausal women, aged 45 to 85 years and without clinical CVD (2000-2002), from the Multi-Ethnic Study of Atherosclerosis. Participants were classified as having or not having early menopause. NT-proBNP was log-transformed. Multivariable linear regression was used for analysis. RESULTS: Five hundred sixty-one women had early menopause. The median (25th-75th percentiles) NT-proBNP value was 79.0 (41.1-151.6) pg/mL for all participants, 83.4 (41.4-164.9) pg/mL for women with early menopause, and 78.0 (40.8-148.3) pg/mL for women without early menopause. The mean (SD) age was 65 (10.1) and 65 (8.9) years for women with and without early menopause, respectively. No significant interactions between menopause age and ethnicity were observed. In multivariable analysis, early menopause was associated with a 10.7% increase in NT-proBNP levels, whereas each 1-year increase in menopause age was associated with a 0.7% decrease in NT-proBNP levels. CONCLUSIONS: Early menopause is associated with greater NT-proBNP levels, whereas each 1-year increase in menopause age is associated with lower NT-proBNP levels, in postmenopausal women.
OBJECTIVE: Menopause age can affect the risk of developing cardiovascular disease (CVD). The purpose of this study was to investigate the associations of early menopause (menopause occurring before age 45 y) and menopause age with N-terminal pro brain natriuretic peptide (NT-proBNP), a potential risk marker of CVD and heart failure. METHODS: Our cross-sectional study included 2,275 postmenopausal women, aged 45 to 85 years and without clinical CVD (2000-2002), from the Multi-Ethnic Study of Atherosclerosis. Participants were classified as having or not having early menopause. NT-proBNP was log-transformed. Multivariable linear regression was used for analysis. RESULTS: Five hundred sixty-one women had early menopause. The median (25th-75th percentiles) NT-proBNP value was 79.0 (41.1-151.6) pg/mL for all participants, 83.4 (41.4-164.9) pg/mL for women with early menopause, and 78.0 (40.8-148.3) pg/mL for women without early menopause. The mean (SD) age was 65 (10.1) and 65 (8.9) years for women with and without early menopause, respectively. No significant interactions between menopause age and ethnicity were observed. In multivariable analysis, early menopause was associated with a 10.7% increase in NT-proBNP levels, whereas each 1-year increase in menopause age was associated with a 0.7% decrease in NT-proBNP levels. CONCLUSIONS: Early menopause is associated with greater NT-proBNP levels, whereas each 1-year increase in menopause age is associated with lower NT-proBNP levels, in postmenopausal women.
Authors: Sandeep R Das; Mark H Drazner; Daniel L Dries; Gloria L Vega; Harold G Stanek; Shuaib M Abdullah; Russell M Canham; Anne K Chung; David Leonard; Frank H Wians; James A de Lemos Journal: Circulation Date: 2005-10-04 Impact factor: 29.690
Authors: Aditya Jain; Harikrishna Tandri; Darshan Dalal; Harjit Chahal; Elsayed Z Soliman; Ronald J Prineas; Aaron R Folsom; João A C Lima; David A Bluemke Journal: Am Heart J Date: 2010-04 Impact factor: 4.749
Authors: Imo A Ebong; Alain G Bertoni; Elsayed Z Soliman; Mengye Guo; Christopher T Sibley; Yii-Der I Chen; Jerome I Rotter; Yi-Chun Chen; David C Goff Journal: Metab Syndr Relat Disord Date: 2011-11-04 Impact factor: 1.894
Authors: Shunsuke Natori; Shenghan Lai; J Paul Finn; Antoinette S Gomes; W Gregory Hundley; Michael Jerosch-Herold; Gregory Pearson; Shantanu Sinha; Andrew Arai; Joao A C Lima; David A Bluemke Journal: AJR Am J Roentgenol Date: 2006-06 Impact factor: 3.959
Authors: Gabriella Gruden; Federica Barutta; Nish Chaturvedi; Casper Schalkwijk; Coen D Stehouwer; Silvia Pinach; Maria Manzo; Maria Loiacono; Marinella Tricarico; Giulio Mengozzi; Daniel R Witte; John H Fuller; Paolo Cavallo Perin; Graziella Bruno Journal: Diabetes Care Date: 2012-06-14 Impact factor: 19.112
Authors: John P Konhilas; Jessica N Sanchez; Jessica A Regan; Eleni Constantopoulos; Marissa Lopez-Pier; Danielle K Cannon; Rinku Skaria; Laurel A McKee; Hao Chen; Yulia Lipovka; Dennis Pollow; Heddwen L Brooks Journal: Am J Physiol Heart Circ Physiol Date: 2020-05-08 Impact factor: 4.733
Authors: Imo A Ebong; Machelle D Wilson; Duke Appiah; Erin D Michos; Susan B Racette; Amparo Villablanca; Khadijah Breathett; Pamela L Lutsey; Melissa Wellons; Karol E Watson; Patricia Chang; Alain G Bertoni Journal: J Am Heart Assoc Date: 2022-04-13 Impact factor: 6.106
Authors: Yingli Fu; Yaqin Yu; Shibin Wang; Joseph Sam Kanu; Yueyue You; Yingyu Liu; Yangyu Zhang; Yawen Liu; Bo Li; Yuchun Tao; Changgui Kou Journal: Int J Environ Res Public Health Date: 2016-09-22 Impact factor: 3.390